Please assess the completion status of the following clinical trial:

Trial Title: Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* At least mild fatigue in 2 of the 4 areas of the Piper Fatigue Scale (score ≥ 1-3)~* Completion of standard surgery +/- chemotherapy for breast cancer (may undergo radiation therapy during study)~* 25-OH vitamin D \> 20 ng/ml~* Histological evidence of stage I-III hormone receptor-positive breast cancer~* Body Mass Index \>/=18 and \<50 kg/m2~* 40-80 years of age~* Non-smoking (non smoking for at least 12 months: cigarettes, cigars, pipes~* Menopause over one year (absence of menses for 12 months or greater)~* Sedentary (exercise no \>60 min 2 times/week)~Exclusion Criteria:~* Taking oral steroids, warfarin, or other medications interfering with fat metabolism that may not be safely discontinued temporarily for specific produces (i.e. for 72 hours prior)~* Symptomatic heart disease, coronary artery disease, congestive heart failure, or uncontrolled hypertension (systolic blood pressure over 180 mm HG)unless medically stabilized~* Participant is, in the opinion of the investigator, unable to adhere to the study protocol due to medical or orthopedic conditions that limit ability to exercise or travel to the Baltimore VA for protocol procedures~* Chronic pulmonary disease (on supplemental O2)~* Abnormal renal function (BUN above 40 mg/dl, Cr above 1.3 mg/dl, CrCl\<60mg/dl)~* Unstable lymphedema~* Evidence of cancer metastases or recurrence~* Anemia HCT below 30 mg/dl, platelets below 80,000/cm3~* Type 1 diabetes; insulin treatment for diabetes, poorly controlled diabetes, HgA1c\>10%~* Abnormal response to exercise test (ST segment depression greater than 2mm, chest pain, significant arrhythmias, extreme shortness of breath, cyanosis, exercising BP above 240/120 mm HG, or other contraindications to exercise) confirmed with further diagnostic evaluations.~* Abnormal liver function~* Untreated dyslipidemia with National Cholesterol ATPIII 10 year cardiac risk score greater than 10% (www.nhlbi.nih.gov/guidelines/cholesterol/atp3upd04.htm)~* Metal implants or devices (i.e. pacemaker) if undergoing CT scan~* History of seizures or taking anti-seizure or anti convulsion medication~* Allergic to lidocaine~* Mini-mental state examination below 24, dementia, or unstable clinical depression by exam

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Structured Exercise (Type: EXPERIMENTAL): Structured and supervised aerobic and resistance training 2 times per week
- Usual Care (Type: ACTIVE_COMPARATOR): Subjects will be counseled on American Cancer Society and American College of Sports Medicine physical activity and nutritional guidelines at the initiation of the study. Study participants will be contacted by a physician or nurse on weeks 2, 6, 10, and 14 to provide support and encouragement to patients.

Based on this trial design, predict the completion outcome and termination type (if applicable).